Chemotherapy-induced nausea and vomiting: Contemporary approaches to optimal management

Steven Grunberg, Rebecca A. Clark-Snow, Jim Koeller

    Research output: Contribution to journalArticle

    18 Scopus citations

    Abstract

    Introduction: Chemotherapy-induced nausea and vomiting remains a significant problem for cancer patients. Discussion: Patient factors such as polypharmacy, medication costs, mucositis, and depression may hinder good antiemetic control, while high workloads, poor communication, and underestimation of the problem on the part of healthcare professionals also play a role. Improving outcomes requires accurate assessment of risk factors, use of guidelines, and better adherence to antiemetic regimens. Conclusion: Extended-release formulations and new delivery systems such as transdermal patches, nasal sprays, and pumps provide a new strategy that may improve patient outcomes.

    Original languageEnglish (US)
    Pages (from-to)S1-S10
    JournalSupportive Care in Cancer
    Volume18
    Issue numberSUPPL. 1
    DOIs
    Publication statusPublished - Mar 1 2010

      Fingerprint

    Keywords

    • Chemotherapy-induced nausea and vomiting
    • Cisplatin-based therapy
    • Neurokinin-1 inhibitor
    • Selective 5-hydroxytrytamine 3

    ASJC Scopus subject areas

    • Oncology

    Cite this